Xoma | XOMA - Ebit


Xoma reported $-10.08M in EBIT for its fiscal quarter ending in June of 2024.





Ebit Change Date
AbbVie USD 5.81B 4.36B Dec/2025
Agenus USD 14.4M 19.26M Dec/2025
Agios Pharmaceuticals USD -121.58M 4.71M Dec/2025
Ardelyx USD 5.1M 2.02M Dec/2025
aTyr Pharma USD 24.47M 24.7M Dec/2025
BioMarin Pharmaceutical USD 198.39M 230.08M Dec/2025
Celldex Therapeutics USD -87.15M 13.54M Dec/2025
Curis USD -7.88M 4.31M Dec/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
Incyte USD 383.88M 47.44M Dec/2025
MacroGenics USD -12.1M 32.26M Dec/2025
Novartis USD 4.06B 530M Dec/2025
Novartis USD 4.06B 413M Dec/2025
Pfizer USD 4.65B 71M Dec/2025
Prothena USD -27.21M 12.55M Dec/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Xoma USD -10.08M 4.4M Jun/2024